SAN FRANCISCO — Ophthalmic leaders stand poised to tackle ongoing clinical and regulatory challenges in the years ahead, Eric D. Donnenfeld, MD, the newly installed president of the American Society of Cataract and Refractive Surgery, said here.Donnenfeld was installed during the opening ceremonies at the annual ASCRS meeting. He accepted the mantle of leadership from his predecessor, David F. Chang, MD.
SAN FRANCISCO — A stumbling block to inserting a bag-in-the-lens IOL may be overcome with the use of a femtosecond laser, according to a presenter here.The original bag-in-the-lens IOL insertion technique, which is not approved by the U.S. Food and Drug Administration, was designed to prevent posterior capsule opacification in pediatric and adult cataract patients, Ana Paula Canto, MD, said at the American Society of Cataract and Refractive Surgery meeting. However, the technique for bag-in-the-lens IOL insertion is considered difficult because centration depends on an appropriately sized and centered capsulorrhexis.
SAN FRANCISCO — Benefits of femtosecond laser-assisted keratoplasty, particularly for deep anterior lamellar keratoplasty, include improved corrected distance visual acuity, a decrease in the complication rate, more precise placement of the air needle, and ease of conversion to full-thickness penetrating keratoplasty if Descemet’s membrane is perforated, according to a speaker.Reporting early outcomes of results of femtosecond laser-assisted DALK in 31 eyes, Ijeoma M. Asota, MD, said at the American Society of Cataract and Refractive Surgery meeting, “We did notice an early and steady improvement in corrected distance visual acuity.”
SAN FRANCISCO — The ability to overlay graphical data on video images when creating precise limbal relaxing incisions and optimizing capsulorrhexis size and shape is a prime feature of the Callisto eye surgical management system introduced here by Carl Zeiss Meditec.Increased efficiency created by the integration of the documentation, workflow support and surgical assistance functions of the system will improve clinical outcomes, Ludwin Monz, PhD, president and CEO of Carl Zeiss Meditec, said at a media briefing at the American Society of Cataract and Refractive Surgery meeting.
The U.S. Food and Drug Administration approved Simbrinza suspension, a fixed-dose combination therapy without a beta blocker, to reduce IOP in patients with primary open-angle glaucoma or ocular hypertension, according to a press release from Alcon.The…
By: Mio